Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

v3.19.3
Document and Entity Information - shares
9 Months Ended
Sep. 30, 2019
Nov. 19, 2019
Document And Entity Information    
Entity Registrant Name ENDONOVO THERAPEUTICS, INC.  
Entity Central Index Key 0001528172  
Document Type 10-Q  
Document Period End Date Sep. 30, 2019  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business Flag true  
Entity Emerging Growth Company true  
Entity Ex Transition Period true  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   930,744,770
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2019